{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:11:53Z","timestamp":1767625913933},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.1016\/s0924-8579(98)00102-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T16:09:59Z","timestamp":1027613399000},"page":"213-219","source":"Crossref","is-referenced-by-count":47,"title":["Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent"],"prefix":"10.1016","volume":"12","author":[{"given":"Elias K.","family":"Manavathu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranatharthi H.","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0924-8579(98)00102-2_BIB1","unstructured":"Manavathu EK, Alangaden GJ, Lerner SA. Isolation and characterization of itraconazole-resistant mutants of Aspergillus fumigatus. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995: American Society for Microbiology, Washington DC, USA, Abstract C, p. 570."},{"key":"10.1016\/S0924-8579(98)00102-2_BIB2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/clinids\/19.4.687","article-title":"Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review","volume":"19","author":"White","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.41.7.1488","article-title":"The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14\u03b1-demethylase in Candida albicans","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB4","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","article-title":"Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB5","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB6","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/AAC.40.10.2300","article-title":"Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors","volume":"40","author":"Sanglard","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/S0924-8579(98)00102-2_BIB7","first-page":"83","article-title":"A rapid colorometric method for the study of resistance mechanism to azole antifungal agents on yeasts","volume":"3","author":"Sanglard","year":"1997","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB8","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB9","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.41.7.1504","article-title":"Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus","volume":"41","author":"Oakley","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"10.1016\/S0924-8579(98)00102-2_BIB10","first-page":"81","article-title":"In vitro susceptibility of itraconazole-resistant isolates of Aspergillus fumigatus to voriconazole","volume":"3","author":"Manavathu","year":"1997","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB11","first-page":"378","article-title":"In vitro activities of voriconazole, itraconazole and amphotericin B against Aspergillus species. Abstracts of the 35th Annual Meeting of Infectious Diseases Society of America","volume":"25","author":"Abraham","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1139\/m96-123","article-title":"A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus","volume":"42","author":"Manavathu","year":"1996","journal-title":"Can J Microbiol"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/AAC.39.2.314","article-title":"Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi","volume":"39","author":"Espinel-Ingroff","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0924-8579(98)00102-2_BIB14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin Microbiol Rev"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857998001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857998001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T02:07:03Z","timestamp":1578708423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857998001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["S0924857998001022"],"URL":"https:\/\/doi.org\/10.1016\/s0924-8579(98)00102-2","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}